跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atropan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Atropan
Approved
STANDARD
Atropan
Zhejiang Ruixin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4d46600807d51096
Company
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
4d46600807d51096
Drug Approval Philippines Name
Atropan
Product Name
Atropan
Registration Number
DR-XY42235
Brand Name
Atropan
Generic Name
Atropine Sulfate
Dosage Form
Solution For Injection
Dosage Strength
1mg/mL
Manufacturer
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Importer
Global Pharmatrade
Distributor
Global Pharmatrade
Issuance Date
26 July 2023
Expiry Date
16 July 2028
Pharmacologic Category
Anticholinergics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4d46600807d51096
Type
Standard
Back to Philippines FDA Approvals